Skip to content

Silimed Benelux: what changed

What changed

Silimed Benelux

BE 0794.305.284
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€330,298
2024 · -€339,357+€9,059
Equity
-€809,778
2024 · -€479,480-€330,298
Cash
€144,016
2024 · €33,256+€110,760
Balance sheet total
€1.5m
2024 · €1.1m+€377,236

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€233,567

    up €233,567 (+26.6%), from €877,901 to €1.1m

    of which Trade receivables: +€238,047

  • Cash +€110,760

    up €110,760 (+333%), from €33,256 to €144,016

    mainly Trade debts (+€541,328) and Other debts (+€91,121)

  • Stocks and contracts +€37,440

    up €37,440 (+17.2%), from €218,109 to €255,549

Equity and liabilities
  • Trade debts +€541,328

    up €541,328 (+79.0%), from €684,855 to €1.2m

  • Profit (loss) carried forward -€330,298

    down €330,298 (-62.4%), from -€529,480 to -€859,778

  • Other debts +€91,121

    up €91,121 (+10.5%), from €863,831 to €954,952

  • Tax, wage and social debts +€69,893

    up €69,893 (+105%), from €66,340 to €136,233

    of which Remuneration and social security: +€57,084

Income statement
  • Gross operating margin +€118,503

    up €118,503 (+343%), from €34,531 to €153,033

  • Staff costs +€88,713

    up €88,713 (+23.9%), from €370,902 to €459,616

  • Write-downs +€17,541

    up €17,541 (+15,946%), from €110 to €17,651

  • Financial charges +€3,566

    up €3,566 (+330,213%), from €1 to €3,567

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€339,357
Gross operating margin +€118,503
Staff costs -€88,713
Depreciation +€134
Write-downs -€17,541
Other operating charges -€381
Financial income +€1
Financial charges -€3,566
Taxes +€623
Result 2025 -€330,298
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€110,760
Investment €0
Financing €0
Cash 2024 €33,256
Net result for the year -€330,298
Depreciation +€2,141
Stocks and contracts -€37,440
Receivables within one year -€233,567
Deferred charges and accrued income +€2,390
Trade debts +€541,328
Tax, wage and social debts +€69,893
Advances received +€5,192
Other debts +€91,121
Cash 2025 €144,016
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,135,546 €1,512,782 +€377,236 +33.2%
Fixed assets 21/28 €3,890 €1,749 -€2,141 -55.0%
Tangible fixed assets 22/27 €3,890 €1,749 -€2,141 -55.0%
Plant, machinery and equipment 23 €1,862 €1,657 -€205 -11.0%
Furniture and vehicles 24 €2,028 €92 -€1,936 -95.5%
Current assets 29/58 €1,131,656 €1,511,033 +€379,377 +33.5%
Stocks and contracts in progress 3 €218,109 €255,549 +€37,440 +17.2%
Stocks 30/36 €218,109 €255,549 +€37,440 +17.2%
Amounts receivable within one year 40/41 €877,901 €1,111,468 +€233,567 +26.6%
Trade receivables 40 €304,226 €542,273 +€238,047 +78.2%
Other amounts receivable 41 €573,675 €569,195 -€4,480 -0.8%
Cash at bank and in hand 54/58 €33,256 €144,016 +€110,760 +333%
Deferred charges and accrued income 490/1 €2,390 €0 -€2,390 -100%
Total equity and liabilities 10/49 €1,135,546 €1,512,782 +€377,236 +33.2%
Equity 10/15 -€479,480 -€809,778 -€330,298 -68.9%
Contributions 10/11 €50,000 €50,000 = 0.0%
Profit (loss) carried forward 14 -€529,480 -€859,778 -€330,298 -62.4%
Amounts payable 17/49 €1,615,026 €2,322,560 +€707,534 +43.8%
Amounts payable within one year 42/48 €1,615,026 €2,322,560 +€707,534 +43.8%
Trade debts 44 €684,855 €1,226,183 +€541,328 +79.0%
Suppliers 440/4 €684,855 €1,226,183 +€541,328 +79.0%
Advances received on contracts in progress 46 - €5,192 +€5,192
Taxes, remuneration and social security 45 €66,340 €136,233 +€69,893 +105%
Taxes 450/3 - €12,809 +€12,809
Remuneration and social security 454/9 €66,340 €123,424 +€57,084 +86.0%
Other amounts payable 47/48 €863,831 €954,952 +€91,121 +10.5%
Accrued charges and deferred income 492/3 €0 - =
Remuneration, social security and pensions 62 €370,902 €459,616 +€88,713 +23.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,274 €2,141 -€134 -5.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €110 €17,651 +€17,541 +15,946%
Other operating charges 640/8 €0 €381 +€381
Gross operating margin 9900 €34,531 €153,033 +€118,503 +343%
Operating profit (loss) 9901 -€338,756 -€326,755 +€12,002 +3.5%
Financial income 75/76B €0 €1 +€1 +285%
Recurring financial income 75 €0 €1 +€1 +285%
Financial charges 65/66B €1 €3,567 +€3,566 +330,213%
Recurring financial charges 65 €1 €3,567 +€3,566 +330,213%
Profit (loss) for the period before taxes 9903 -€338,757 -€330,321 +€8,436 +2.5%
Income taxes 67/77 €600 -€23 -€623
Profit (loss) for the period 9904 -€339,357 -€330,298 +€9,059 +2.7%
Profit (loss) for the period to be appropriated 9905 -€339,357 -€330,298 +€9,059 +2.7%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.